NCT03384160View on ClinicalTrials.gov

Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial.

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

October 30, 2018

Study Completion Date

December 4, 2018

Conditions
PainTeeth, Impacted
Interventions
DIAGNOSTIC_TEST

Group 1 -Pain monitor

Use of the anesthetic Mepivacaine 2% in third molar extraction and evaluation in postoperative

DIAGNOSTIC_TEST

Group 2 -Pain monitor

Use of the anesthetic Articaine 4% in third molar extraction and evaluation in postoperative

Trial Locations (1)

12245000

Michelle Bianchi de Moraes, São José dos Campos

All Listed Sponsors
collaborator

Prof. Dr. Fernando Vagner Raldi

UNKNOWN

collaborator

Paula Carolina de Almeida

UNKNOWN

lead

Universidade Estadual Paulista Júlio de Mesquita Filho

OTHER

NCT03384160 - Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial. | Biotech Hunter | Biotech Hunter